Venous and arterial thromboembolic events with immune checkpoint inhibitors: A systematic review

Immune-related adverse events of checkpoint inhibitors

(2020) Manuel Ramos-Casals et al.   Nature Reviews Disease Primers

Cardiac Complications Associated With Checkpoint Inhibition: A Systematic Review of the Literature in an Important Emerging Area

(2018) Hassan Mir et al.   CANADIAN JOURNAL OF CARDIOLOGY

Mechanism and management of cancer-associated thrombosis

(2018) Mikio Mukai et al.   Journal of Cardiology

Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors

(2018) Daniel Y. Wang et al.   JAMA Oncology

Risk of Arterial Thromboembolism in Patients With Cancer

(2017) Babak B. Navi et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Cancer-associated venous thromboembolism: Burden, mechanisms, and management

(2017) Ingrid Pabinger et al.   THROMBOSIS AND HAEMOSTASIS

The humanistic and economic burden of venous thromboembolism in cancer patients

(2015) Georgia Kourlaba et al.   BLOOD COAGULATION & FIBRINOLYSIS

Epidemiology of cancer-associated venous thrombosis

(2013) J. F. Timp et al.   BLOOD

Use of Glucocorticoids and Risk of Venous Thromboembolism

(2013) Sigrun A. Johannesdottir et al.   JAMA Internal Medicine

Incidence of venous thromboembolism in patients with cancer – A cohort study using linked United Kingdom databases

(2012) Alex J. Walker et al.   EUROPEAN JOURNAL OF CANCER

Global Variation in the Relative Burden of Stroke and Ischemic Heart Disease

(2011) Anthony S. Kim et al.   CIRCULATION

Chemotherapy-associated thromboembolic risk in cancer outpatients and effect of nadroparin thromboprophylaxis: results of a retrospective analysis of the PROTECHT study

(2011) Sandro Barni et al.   Journal of Translational Medicine